Categories: All postsHealth

Treatment.com AI CEO Dr. Essam Hamza interview at Cantech 24

Dr. Essam Hamza says all the pieces are in place.

The lifelong physician and technology entrepreneur is known to some Canadian investors as the founder of CloudMD. But he says Treatment.com AI (Treatment.com AI Stock Quote, Chart, News, Analysts, Financials CSE:TRUE) is taking the next great leap in healthcare technology.

“The one piece that was missing from that company is what Treatment has,” he said. “I was really excited at the end of last year to join Treatment.com AI as the CEO. “There are only a handful of companies around the world that have this type of technology. We think we have one of the better solutions, and it’s really transforming the way that healthcare is going to be delivered in the future.” Hamza says doctors in Canada are growing frustrated because for every five minutes they spend with a patient they are then spending twenty or thirty minutes on paperwork. The solution, he says, is right there is his company’s name.

“The solution,” Hamza told MacArthur, “is using AI tools to help triage and onboard patients in doing all the admin work for the practitioners so that there will be no more guessing on what the patient has, we will know based on diagnostic tools and precision medicine. There will be no more patients just showing up in a clinic or emergency room and we have no idea what they have or why they are there. The tools are there now and they’re only getting better.”

 

For the full interview, see below:

Tagged with: true
Nick Waddell

Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.

Recent Posts

Could AI actually help Thomson Reuters?

Kingwest & Company managing director Tim Regan says Thomson Reuters (Thomson Reuters Stock Quote, Chart, News, Analysts, Financials TSX:TRI) could… [Read More]

13 minutes ago

Is Generac overvalued?

Roth Capital Partners analyst Chip Moore maintained his “Neutral” rating and US$250.00 target on Generac Holdings (Generac Holdings Stock Quote,… [Read More]

26 minutes ago

The Constellation Software bounceback is real, RBC says

RBC Dominion Securities analyst Paul Treiber maintained his “Outperform” rating and $4,400 target on Constellation Software (Constellation Software Stock Quote,… [Read More]

32 minutes ago

RBC raises price target on Fairfax Financial

RBC Dominion Securities analyst Bart Dziarski raised his target on Fairfax Financial Holdings (Fairfax Financial Holdings Stock Quote, Chart, News,… [Read More]

13 hours ago

Analyst explains why Juno Industries is an interesting small cap

Paradigm Capital analyst Alexandra Ricci says Juno Industries (Juno Industries Stock Quote, Chart, News, Analysts, Financials TSXV:JUNO) offers investors a… [Read More]

15 hours ago

It’s time to buy Hammond Power, this analyst says

Paradigm Capital analyst Razi Hasan maintained his “Buy” rating and $380.00 target on Hammond Power Solutions (Hammond Power Solutions Stock… [Read More]

17 hours ago